TY - JOUR
T1 - Tackling the 3 big challenges confronting health technology assessment development in Asia
T2 - a commentary
AU - Teerawattananon, Yot
AU - Teo, Yik Ying
AU - Dabak, Saudamini
AU - Rattanavipapong, Waranya
AU - Isaranuwatchai, Wanrudee
AU - Wee, Hwee-Lin
AU - Luo, Nan
AU - Morton, Alec
PY - 2020/5/1
Y1 - 2020/5/1
N2 - There has been continuous development in the field of health technology assessment (HTA) owing to the added value of HTA in supporting healthcare reimbursement decisions. Collaboration and engagement among countries in Asia has been carried out to share experiences and learning on the barriers and factors facilitating the implementation and use of HTA in policy making. A symposium on the topic of Health Technology Assessment (HTA): Selecting the Highest Value Care was held on January 10, 2019 at the National University of Singapore, during which 3 major challenges confronting HTA development in Asia were identified. The symposium also offered possible ways to overcome the challenges.
AB - There has been continuous development in the field of health technology assessment (HTA) owing to the added value of HTA in supporting healthcare reimbursement decisions. Collaboration and engagement among countries in Asia has been carried out to share experiences and learning on the barriers and factors facilitating the implementation and use of HTA in policy making. A symposium on the topic of Health Technology Assessment (HTA): Selecting the Highest Value Care was held on January 10, 2019 at the National University of Singapore, during which 3 major challenges confronting HTA development in Asia were identified. The symposium also offered possible ways to overcome the challenges.
KW - health technology assessment
KW - HTA
KW - HTA in Asia
KW - priority setting
KW - health care
U2 - 10.1016/j.vhri.2019.07.001
DO - 10.1016/j.vhri.2019.07.001
M3 - Comment/debate
SN - 2212-1099
VL - 21
SP - 66
EP - 68
JO - Value in Health Regional Issues
JF - Value in Health Regional Issues
ER -